Interface Recherche Fondamentale et Appliquée en Cancérologie - IRFAC - UMRS1113

  • Flux RSS
(1 - 20 of 255)

Pages

 La mésalazine diminue la viabilité et la formation de colonosphères de lignées de cancers coliques (CC) humains : nouvelle approche pour élucider ses effets préventifs des CC compliquant les maladies inflammatoires chroniques intestinales (MICI) coliques
588: Modulation of CXCR4/CXL12 axis by hypoxia and pharmacological drug combination in colon cancer
Adherence and Patients' Attitudes to Oral Anticancer Drugs: A Prospective Series of 201 Patients Focusing on Targeted Therapies
Adjuvant chemotherapy in elderly patients with early breast cancer. Impact of age and comprehensive geriatric assessment on tumor board proposals
Advanced chondrosarcomas: role of chemotherapy and survival
Age impacts the pattern of care for elderly patients with rectal cancer
AKT signals to constitutively active androgen receptor variants in prostate cancer
Analyse rétrospective de la survie sans récidive, de la survie globale et des facteurs pronostiques chez 119 patients opérés à visée curative d’un adénocarcinome pancréatique et recevant un traitement adjuvant par gemcitabine
Androgen receptor variants and microenvironment In Prostate Cancer
Androgen receptor variants and microenvironment in Prostate Cancer
[Androgen receptor variants in prostate cancer]
Anisotropic daughter cell telophase movement and mNumb distribution controled by the Apc tumour suppressor gene are altered in the early steps of colon cancerogenesis
Anti-cetuximab IgE ELISA for identification of patients at a high risk of cetuximab-induced anaphylaxis
Approaching tumour therapy beyond platinum drugs Status of the art and perspectives of ruthenium drug candidates
Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: focus on the cancer hallmark of tumor angiogenesis
Assessing the carcinogenic potential of low-dose exposures to chemical mixtures in the environment: the challenge ahead
Baseline cognitive functions among elderly patients with localised breast cancer
Baseline nutritional status is prognostic factor after definitive radiochemotherapy for esophageal cancer
Bevacizumab plus capecitabine in patients with progressive advanced well-differentiated neuroendocrine tumors of the gastro-intestinal (GI-NETs) tract (BETTER trial) - A phase II non-randomised trial
Bevacizumab plus microtubule targeting agents in heavily pre-treated ovarian cancer patients: a retrospective study

Pages

Islandora displays